Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

NewAmsterdam Pharma (NAMS) Debt Ratio (2022 - 2025)

NewAmsterdam Pharma (NAMS) has disclosed Debt Ratio for 4 consecutive years, with 0.07 as the latest value for Q4 2025.

  • Quarterly Debt Ratio rose 71.59% to 0.07 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.07 through Dec 2025, up 71.59% year-over-year, with the annual reading at 0.07 for FY2025, 71.59% up from the prior year.
  • Debt Ratio hit 0.07 in Q4 2025 for NewAmsterdam Pharma, up from 0.06 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.07 in Q4 2025 to a low of 0.01 in Q4 2022.
  • Historically, Debt Ratio has averaged 0.04 across 4 years, with a median of 0.04 in 2024.
  • Biggest five-year swings in Debt Ratio: skyrocketed 373.77% in 2023 and later tumbled 57.53% in 2025.
  • Year by year, Debt Ratio stood at 0.01 in 2022, then surged by 373.77% to 0.04 in 2023, then rose by 19.77% to 0.04 in 2024, then soared by 71.59% to 0.07 in 2025.
  • Business Quant data shows Debt Ratio for NAMS at 0.07 in Q4 2025, 0.06 in Q3 2025, and 0.03 in Q2 2025.